Katariina Öörni

7.0k total citations · 2 hit papers
110 papers, 5.4k citations indexed

About

Katariina Öörni is a scholar working on Surgery, Immunology and Molecular Biology. According to data from OpenAlex, Katariina Öörni has authored 110 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Surgery, 40 papers in Immunology and 39 papers in Molecular Biology. Recurrent topics in Katariina Öörni's work include Atherosclerosis and Cardiovascular Diseases (35 papers), Lipoproteins and Cardiovascular Health (26 papers) and Cholesterol and Lipid Metabolism (23 papers). Katariina Öörni is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (35 papers), Lipoproteins and Cardiovascular Health (26 papers) and Cholesterol and Lipid Metabolism (23 papers). Katariina Öörni collaborates with scholars based in Finland, Sweden and United States. Katariina Öörni's co-authors include Petri T. Kovanen, Magnus Bäck, Ira Tabas, Arif Yurdagul, Markku O. Pentikäinen, Kristiina Rajamäki, Kari K. Eklund, Mika Ala‐Korpela, Jani Lappalainen and Sampsa Matikainen and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Katariina Öörni

105 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

2019 1.1k citations Katariina Öörni, Petri T. Kovanen et al. profile →
Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation

2010 776 citations Kristiina Rajamäki, Jani Lappalainen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katariina Öörni Finland	33	2.2k	1.9k	1.5k	887	826	110	5.4k
Patricia G. Yancey United States	38	2.4k 1.1×	1.3k 0.7×	2.5k 1.7×	688 0.8×	772 0.9×	70	5.7k
Christina A. Bursill Australia	38	1.4k 0.6×	1.1k 0.6×	1.1k 0.7×	704 0.8×	546 0.7×	133	4.7k
Tomáš Vaisar United States	43	1.6k 0.7×	953 0.5×	1.3k 0.8×	571 0.6×	572 0.7×	127	4.7k
Mary G. Sorci‐Thomas United States	38	1.8k 0.8×	1.0k 0.5×	1.8k 1.2×	559 0.6×	559 0.7×	85	4.4k
Elsa Sánchez‐López Spain	38	4.1k 1.8×	2.2k 1.2×	636 0.4×	1.1k 1.3×	793 1.0×	53	7.7k
Anthony J. Valente United States	55	2.9k 1.3×	3.2k 1.7×	1.5k 1.0×	1.1k 1.3×	1.0k 1.2×	122	8.9k
W. Gray Jerome United States	39	1.9k 0.9×	729 0.4×	1.8k 1.2×	751 0.8×	497 0.6×	107	4.9k
Yury I. Miller United States	53	3.0k 1.4×	4.2k 2.2×	1.5k 1.0×	1.5k 1.7×	727 0.9×	102	8.4k
José Luis Martín‐Ventura Spain	49	2.6k 1.2×	1.8k 1.0×	1.7k 1.1×	835 0.9×	1.3k 1.6×	189	7.2k
Heidi Noels Germany	29	2.9k 1.3×	2.0k 1.1×	755 0.5×	616 0.7×	2.1k 2.5×	72	6.2k

Countries citing papers authored by Katariina Öörni

Since Specialization

Citations

This map shows the geographic impact of Katariina Öörni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katariina Öörni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katariina Öörni more than expected).

Fields of papers citing papers by Katariina Öörni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katariina Öörni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katariina Öörni. The network helps show where Katariina Öörni may publish in the future.

Co-authorship network of co-authors of Katariina Öörni

This figure shows the co-authorship network connecting the top 25 collaborators of Katariina Öörni. A scholar is included among the top collaborators of Katariina Öörni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katariina Öörni. Katariina Öörni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lehti, Satu, Matti Jauhiainen, Anna Kankaanpää, et al.. (2025). Association of aerobic fitness and body composition with protein and major lipid class composition of high-density lipoprotein. American Journal of Physiology-Endocrinology and Metabolism. 329(2). E368–E381.

Öörni, Katariina, et al.. (2024). Deletion of the Murine Ortholog of the Human 9p21.3 Locus Leads to Insulin Resistance and Obesity in Hypercholesterolemic Mice. Cells. 13(11). 983–983. 2 indexed citations

Gylling, Helena, et al.. (2023). High cholesterol absorption, a potential risk factor for atherosclerosis. A possible proatherogenic mechanism in a cohort study. Atherosclerosis. 379. S132–S132. 2 indexed citations

Simonen, Piia, et al.. (2023). High cholesterol absorption: A risk factor of atherosclerotic cardiovascular diseases?. Atherosclerosis. 376. 53–62. 18 indexed citations

Lorey, Martina B., Martin Hermansson, Julia M. Assini, et al.. (2023). Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages. Frontiers in Cardiovascular Medicine. 10. 1130162–1130162. 7 indexed citations

Neuvonen, Maarit, Erja Kerkelä, Kati Hyvärinen, et al.. (2023). OxLDL sensitizes platelets for increased formation of extracellular vesicles capable of finetuning macrophage gene expression. European Journal of Cell Biology. 102(2). 151311–151311. 10 indexed citations

Christensen, Jacob J., Ingunn Narverud, Maija Ruuth, et al.. (2021). Children with familial hypercholesterolemia display changes in LDL and HDL function: A cross‐sectional study. Journal of Internal Medicine. 290(5). 1083–1097. 8 indexed citations

Öörni, Katariina & Petri T. Kovanen. (2021). Aggregation Susceptibility of Low-Density Lipoproteins—A Novel Modifiable Biomarker of Cardiovascular Risk. Journal of Clinical Medicine. 10(8). 1769–1769. 23 indexed citations

Nissilä, Eija, Hanna Ruhanen, Martina B. Lorey, et al.. (2021). Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles. iScience. 24(6). 102535–102535. 6 indexed citations

10.

Erkkilä, Arja T., Minna Holopainen, Maija Ruuth, et al.. (2021). Lipidomic changes of LDL after consumption of Camelina sativa oil, fatty fish and lean fish in subjects with impaired glucose metabolism—A randomized controlled trial. Journal of clinical lipidology. 15(5). 743–751. 9 indexed citations

11.

Nguyen, Su Duy, Emilia A. Korhonen, Martina B. Lorey, et al.. (2021). Lysophosphatidylcholine in phospholipase A2-modified LDL triggers secretion of angiopoietin 2. Atherosclerosis. 327. 87–99. 8 indexed citations

12.

Lee‐Rueckert, Miriam, Jani Lappalainen, Tommy Nordström, et al.. (2020). Acidic extracellular pH promotes accumulation of free cholesterol in human monocyte-derived macrophages via inhibition of ACAT1 activity. Atherosclerosis. 312. 1–7. 12 indexed citations

13.

Pedrelli, Matteo, R Denis, Katariina Öörni, et al.. (2019). Insights From Liver‐Humanized Mice on Cholesterol Lipoprotein Metabolism and LXR‐Agonist Pharmacodynamics in Humans. Hepatology. 72(2). 656–670. 23 indexed citations

14.

Nguyen, Su Duy, Mikko I. Mäyränpää, Kristiina Rajamäki, et al.. (2018). Human mast cell neutral proteases generate modified LDL particles with increased proteoglycan binding. Atherosclerosis. 275. 390–399. 18 indexed citations

15.

Robciuc, Marius R., Marianna Maranghi, Daniel J. Rader, et al.. (2013). Angptl3 Deficiency Is Associated With Increased Insulin Sensitivity, Lipoprotein Lipase Activity, and Decreased Serum Free Fatty Acids. Arteriosclerosis Thrombosis and Vascular Biology. 33(7). 1706–1713. 138 indexed citations

16.

Nguyen, Su Duy, Katariina Öörni, Miriam Lee‐Rueckert, et al.. (2012). Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells. Journal of Lipid Research. 53(10). 2115–2125. 26 indexed citations

17.

Chen, Jie, et al.. (2008). In situ delipidation of low-density lipoproteins in capillary electrochromatography yields apolipoprotein B-100-coated surfaces for interaction studies. Analytical Biochemistry. 383(1). 38–43. 6 indexed citations

18.

Soininen, Pasi, Katariina Öörni, Hannu Maaheimo, et al.. (2007). 1H NMR at 800MHz facilitates detailed phospholipid follow-up during atherogenic modifications in low density lipoproteins. Biochemical and Biophysical Research Communications. 360(1). 290–294. 15 indexed citations

19.

Lindstedt, Ken A., et al.. (2006). Angiotensin II increases expression and secretion of cathepsin F in cultured human monocyte-derived macrophages: An angiotensin II type 2 receptor-mediated effect. Atherosclerosis. 192(2). 323–327. 21 indexed citations

20.

Lindstedt, Leena, Miriam Lee, Katariina Öörni, Dieter Brömme, & Petri T. Kovanen. (2003). Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells. Biochemical and Biophysical Research Communications. 312(4). 1019–1024. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact